The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of antimicrobial agents 2008-08, Vol.32 (2), p.195-196
Hauptverfasser:	Tkalcević, Vanesa Ivetić, Bosnjak, Berislav, Pasalić, Ivanka, Hrvacić, Boska, Situm, Kristina, Kramarić, Miroslava Dominis, Glojnarić, Ines, Eraković Haber, Vesna
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use Clarithromycin - pharmacology Clarithromycin - therapeutic use Disease Models, Animal Escherichia coli - metabolism Escherichia coli Infections - drug therapy Escherichia coli Infections - mortality Humans Lipopolysaccharides - administration & dosage Mice Mice, Inbred BALB C Shock, Septic - drug therapy Shock, Septic - mortality Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!